159 related articles for article (PubMed ID: 26778002)
1. The modulatory effect of TLR2 on LL-37-induced human mast cells activation.
Zhang YY; Yu YY; Zhang YR; Zhang W; Yu B
Biochem Biophys Res Commun; 2016 Feb; 470(2):368-374. PubMed ID: 26778002
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of the Toll-like receptor 2 agonists, PGN and Pam3CSK4 on anti-IgE induced human mast cell activation.
Yu Y; Yip KH; Tam IY; Sam SW; Ng CW; Zhang W; Lau HY
PLoS One; 2014; 9(11):e112989. PubMed ID: 25398056
[TBL] [Abstract][Full Text] [Related]
3. Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2.
Tancowny BP; Karpov V; Schleimer RP; Kulka M
Immunology; 2010 Oct; 131(2):220-30. PubMed ID: 20497485
[TBL] [Abstract][Full Text] [Related]
4. LL-37-induced human mast cell activation through G protein-coupled receptor MrgX2.
Yu Y; Zhang Y; Zhang Y; Lai Y; Chen W; Xiao Z; Zhang W; Jin M; Yu B
Int Immunopharmacol; 2017 Aug; 49():6-12. PubMed ID: 28549244
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2-mediated MAPKs and NF-κB activation requires the GNAO1-dependent pathway in human mast cells.
Jin M; Yu B; Zhang W; Zhang W; Xiao Z; Mao Z; Lai Y; Lin D; Ma Q; Pan E; Zhang Y; Yu Y
Integr Biol (Camb); 2016 Sep; 8(9):968-75. PubMed ID: 27515449
[TBL] [Abstract][Full Text] [Related]
6. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity.
Supajatura V; Ushio H; Nakao A; Akira S; Okumura K; Ra C; Ogawa H
J Clin Invest; 2002 May; 109(10):1351-9. PubMed ID: 12021251
[TBL] [Abstract][Full Text] [Related]
7. MrgX2‑mediated internalization of LL‑37 and degranulation of human LAD2 mast cells.
Murakami T; Suzuki K; Niyonsaba F; Tada H; Reich J; Tamura H; Nagaoka I
Mol Med Rep; 2018 Dec; 18(6):4951-4959. PubMed ID: 30280189
[TBL] [Abstract][Full Text] [Related]
8. Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity.
Yoshioka M; Fukuishi N; Kubo Y; Yamanobe H; Ohsaki K; Kawasoe Y; Murata M; Ishizumi A; Nishii Y; Matsui N; Akagi M
Biol Pharm Bull; 2008 Feb; 31(2):212-6. PubMed ID: 18239275
[TBL] [Abstract][Full Text] [Related]
9. Effect of the antimicrobial peptide LL-37 on Toll-like receptors 2-, 3- and 4-triggered expression of IL-6, IL-8 and CXCL10 in human gingival fibroblasts.
Into T; Inomata M; Shibata K; Murakami Y
Cell Immunol; 2010; 264(1):104-9. PubMed ID: 20570250
[TBL] [Abstract][Full Text] [Related]
10. The host defense peptide LL-37 triggers release of nucleic acids from human mast cells.
Dahl S; Anders E; Gidlöf O; Svensson D; Nilsson BO
Peptides; 2018 Nov; 109():39-45. PubMed ID: 30308233
[TBL] [Abstract][Full Text] [Related]
11. Human-derived cathelicidin LL-37 directly activates mast cells to proinflammatory mediator synthesis and migratory response.
Bąbolewska E; Brzezińska-Błaszczyk E
Cell Immunol; 2015 Feb; 293(2):67-73. PubMed ID: 25577339
[TBL] [Abstract][Full Text] [Related]
12. Mas-related gene X2 (MrgX2) is a novel G protein-coupled receptor for the antimicrobial peptide LL-37 in human mast cells: resistance to receptor phosphorylation, desensitization, and internalization.
Subramanian H; Gupta K; Guo Q; Price R; Ali H
J Biol Chem; 2011 Dec; 286(52):44739-49. PubMed ID: 22069323
[TBL] [Abstract][Full Text] [Related]
13. Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways.
Yanashima K; Chieosilapatham P; Yoshimoto E; Okumura K; Ogawa H; Niyonsaba F
Immunol Res; 2017 Aug; 65(4):920-931. PubMed ID: 28653285
[TBL] [Abstract][Full Text] [Related]
14. Involvement of hypoxia-inducible factor-1 in the inflammatory responses of human LAD2 mast cells and basophils.
Sumbayev VV; Yasinska I; Oniku AE; Streatfield CL; Gibbs BF
PLoS One; 2012; 7(3):e34259. PubMed ID: 22470546
[TBL] [Abstract][Full Text] [Related]
15. TLR2 Regulates Mast Cell IL-6 and IL-13 Production During
Soria-Castro R; Alfaro-Doblado ÁR; Rodríguez-López G; Campillo-Navarro M; Meneses-Preza YG; Galán-Salinas A; Alvarez-Jimenez V; Yam-Puc JC; Munguía-Fuentes R; Domínguez-Flores A; Estrada-Parra S; Pérez-Tapia SM; Chávez-Blanco AD; Chacón-Salinas R
Front Immunol; 2021; 12():650779. PubMed ID: 34194428
[No Abstract] [Full Text] [Related]
16. Differential Regulation of Mas-Related G Protein-Coupled Receptor X2-Mediated Mast Cell Degranulation by Antimicrobial Host Defense Peptides and Porphyromonas gingivalis Lipopolysaccharide.
Gupta K; Idahosa C; Roy S; Lee D; Subramanian H; Dhingra A; Boesze-Battaglia K; Korostoff J; Ali H
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28694291
[No Abstract] [Full Text] [Related]
17. Antimicrobial peptides human beta-defensins and cathelicidin LL-37 induce the secretion of a pruritogenic cytokine IL-31 by human mast cells.
Niyonsaba F; Ushio H; Hara M; Yokoi H; Tominaga M; Takamori K; Kajiwara N; Saito H; Nagaoka I; Ogawa H; Okumura K
J Immunol; 2010 Apr; 184(7):3526-34. PubMed ID: 20190140
[TBL] [Abstract][Full Text] [Related]
18. Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.
Ji J; von Schéele I; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1035-43. PubMed ID: 27274225
[TBL] [Abstract][Full Text] [Related]
19. A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells.
Kasakura K; Takahashi K; Aizawa T; Hosono A; Kaminogawa S
Int Arch Allergy Immunol; 2009; 150(4):359-69. PubMed ID: 19571568
[TBL] [Abstract][Full Text] [Related]
20. The anti-microbial peptide LL-37 inhibits the activation of dendritic cells by TLR ligands.
Kandler K; Shaykhiev R; Kleemann P; Klescz F; Lohoff M; Vogelmeier C; Bals R
Int Immunol; 2006 Dec; 18(12):1729-36. PubMed ID: 17041145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
